Morgan Stanley’s Harvard Bioscience HBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.1K Sell
29,556
-55,146
-65% -$24.5K ﹤0.01% 6780
2025
Q1
$47.9K Sell
84,702
-193,502
-70% -$110K ﹤0.01% 6281
2024
Q4
$587K Buy
278,204
+117,855
+73% +$249K ﹤0.01% 5356
2024
Q3
$431K Buy
160,349
+94,354
+143% +$254K ﹤0.01% 5467
2024
Q2
$188K Sell
65,995
-14,020
-18% -$40K ﹤0.01% 5713
2024
Q1
$339K Sell
80,015
-139,145
-63% -$590K ﹤0.01% 5503
2023
Q4
$1.17M Buy
219,160
+161,954
+283% +$866K ﹤0.01% 5228
2023
Q3
$246K Sell
57,206
-335,596
-85% -$1.44M ﹤0.01% 5494
2023
Q2
$2.16M Buy
392,802
+391,056
+22,397% +$2.15M ﹤0.01% 4381
2023
Q1
$7.33K Sell
1,746
-1,743
-50% -$7.32K ﹤0.01% 6968
2022
Q4
$9.66K Sell
3,489
-46,758
-93% -$130K ﹤0.01% 6954
2022
Q3
$128K Sell
50,247
-26,985
-35% -$68.7K ﹤0.01% 5950
2022
Q2
$277K Buy
77,232
+64,370
+500% +$231K ﹤0.01% 5727
2022
Q1
$80K Sell
12,862
-5,700
-31% -$35.5K ﹤0.01% 6459
2021
Q4
$131K Buy
18,562
+8,816
+90% +$62.2K ﹤0.01% 6285
2021
Q3
$69K Buy
9,746
+1,289
+15% +$9.13K ﹤0.01% 6565
2021
Q2
$71K Buy
8,457
+320
+4% +$2.69K ﹤0.01% 6504
2021
Q1
$44K Sell
8,137
-24,761
-75% -$134K ﹤0.01% 6405
2020
Q4
$142K Buy
32,898
+22,328
+211% +$96.4K ﹤0.01% 5765
2020
Q3
$33K Sell
10,570
-8,108
-43% -$25.3K ﹤0.01% 5863
2020
Q2
$58K Buy
18,678
+14,178
+315% +$44K ﹤0.01% 5627
2020
Q1
$10K Buy
4,500
+4,000
+800% +$8.89K ﹤0.01% 6011
2019
Q4
$2K Sell
500
-100
-17% -$400 ﹤0.01% 6499
2019
Q3
$2K Sell
600
-67,814
-99% -$226K ﹤0.01% 6478
2019
Q2
$137K Buy
68,414
+60,885
+809% +$122K ﹤0.01% 5182
2019
Q1
$33K Sell
7,529
-78,401
-91% -$344K ﹤0.01% 5836
2018
Q4
$273K Sell
85,930
-25,858
-23% -$82.2K ﹤0.01% 5148
2018
Q3
$587K Buy
111,788
+25,153
+29% +$132K ﹤0.01% 4909
2018
Q2
$463K Buy
86,635
+17,902
+26% +$95.7K ﹤0.01% 5161
2018
Q1
$343K Buy
68,733
+38,971
+131% +$194K ﹤0.01% 5210
2017
Q4
$99K Buy
29,762
+4,316
+17% +$14.4K ﹤0.01% 5635
2017
Q3
$95K Sell
25,446
-8,735
-26% -$32.6K ﹤0.01% 5593
2017
Q2
$88K Buy
34,181
+21,398
+167% +$55.1K ﹤0.01% 5681
2017
Q1
$34K Sell
12,783
-42,553
-77% -$113K ﹤0.01% 5939
2016
Q4
$169K Buy
55,336
+34,333
+163% +$105K ﹤0.01% 5406
2016
Q3
$57K Sell
21,003
-10,273
-33% -$27.9K ﹤0.01% 5531
2016
Q2
$90K Buy
31,276
+30,676
+5,113% +$88.3K ﹤0.01% 5284
2016
Q1
$2K Sell
600
-704
-54% -$2.35K ﹤0.01% 6397
2015
Q4
$4K Buy
1,304
+704
+117% +$2.16K ﹤0.01% 6411
2015
Q3
$2K Sell
600
-9,733
-94% -$32.4K ﹤0.01% 6489
2015
Q2
$59K Sell
10,333
-51,753
-83% -$296K ﹤0.01% 5796
2015
Q1
$361K Sell
62,086
-42,530
-41% -$247K ﹤0.01% 4866
2014
Q4
$594K Sell
104,616
-190,943
-65% -$1.08M ﹤0.01% 4542
2014
Q3
$1.21M Buy
295,559
+56,642
+24% +$232K ﹤0.01% 3882
2014
Q2
$1.09M Buy
238,917
+67,181
+39% +$306K ﹤0.01% 3988
2014
Q1
$814K Sell
171,736
-28,399
-14% -$135K ﹤0.01% 4167
2013
Q4
$941K Sell
200,135
-214,952
-52% -$1.01M ﹤0.01% 3978
2013
Q3
$1.66M Sell
415,087
-98,830
-19% -$394K ﹤0.01% 3393
2013
Q2
$1.83M Buy
+513,917
New +$1.83M ﹤0.01% 3220